466,635 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by IPG Investment Advisors LLC

IPG Investment Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 466,635 shares of the pharmacy operator’s stock, valued at approximately $10,378,000. Walgreens Boots Alliance comprises 2.3% of IPG Investment Advisors LLC’s holdings, making the stock its 16th biggest holding.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in WBA. Vontobel Holding Ltd. raised its holdings in Walgreens Boots Alliance by 104.6% during the 1st quarter. Vontobel Holding Ltd. now owns 36,922 shares of the pharmacy operator’s stock valued at $1,752,000 after buying an additional 18,879 shares during the last quarter. Moors & Cabot Inc. raised its holdings in Walgreens Boots Alliance by 31.1% in the 1st quarter. Moors & Cabot Inc. now owns 20,791 shares of the pharmacy operator’s stock worth $931,000 after purchasing an additional 4,931 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in Walgreens Boots Alliance by 27.9% in the 1st quarter. Sequoia Financial Advisors LLC now owns 7,569 shares of the pharmacy operator’s stock worth $339,000 after purchasing an additional 1,651 shares in the last quarter. Candriam Luxembourg S.C.A. raised its holdings in Walgreens Boots Alliance by 0.5% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock worth $2,842,000 after purchasing an additional 310 shares in the last quarter. Finally, Baird Financial Group Inc. raised its holdings in Walgreens Boots Alliance by 14.2% in the 1st quarter. Baird Financial Group Inc. now owns 467,533 shares of the pharmacy operator’s stock worth $20,932,000 after purchasing an additional 58,184 shares in the last quarter. 57.92% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

WBA has been the subject of several research reports. JPMorgan Chase & Co. upgraded shares of Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $27.00 to $30.00 in a report on Monday, October 23rd. Barclays initiated coverage on shares of Walgreens Boots Alliance in a report on Wednesday, January 3rd. They issued an “underweight” rating and a $21.00 price objective for the company. HSBC initiated coverage on shares of Walgreens Boots Alliance in a report on Friday, December 22nd. They issued a “hold” rating and a $27.00 price objective for the company. Finally, TheStreet upgraded shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a report on Monday, January 8th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $28.25.

Get Our Latest Report on WBA

Insiders Place Their Bets

In other news, Director Nancy M. Schlichting sold 15,209 shares of the business’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $23.05, for a total transaction of $350,567.45. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Nancy M. Schlichting sold 15,209 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $23.05, for a total value of $350,567.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 29th. The stock was purchased at an average price of $22.44 per share, with a total value of $99,992.64. Following the completion of the acquisition, the director now directly owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The disclosure for this purchase can be found here. 17.40% of the stock is owned by insiders.

Walgreens Boots Alliance Price Performance

Shares of WBA stock traded up $0.43 on Monday, reaching $22.67. The company’s stock had a trading volume of 5,011,467 shares, compared to its average volume of 16,646,148. The stock’s fifty day simple moving average is $23.88 and its 200-day simple moving average is $23.59. Walgreens Boots Alliance, Inc. has a 1 year low of $19.68 and a 1 year high of $37.13. The company has a current ratio of 0.66, a quick ratio of 0.30 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $19.55 billion, a price-to-earnings ratio of 34.08, a price-to-earnings-growth ratio of 1.37 and a beta of 0.74.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its earnings results on Thursday, January 4th. The pharmacy operator reported $0.66 earnings per share for the quarter, beating analysts’ consensus estimates of $0.62 by $0.04. The firm had revenue of $36.70 billion during the quarter, compared to analyst estimates of $34.95 billion. Walgreens Boots Alliance had a net margin of 0.40% and a return on equity of 10.48%. Walgreens Boots Alliance’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same period last year, the firm posted $1.16 earnings per share. Analysts forecast that Walgreens Boots Alliance, Inc. will post 3.25 earnings per share for the current fiscal year.

Walgreens Boots Alliance Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 12th. Shareholders of record on Tuesday, February 20th will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 4.41%. The ex-dividend date of this dividend is Friday, February 16th. Walgreens Boots Alliance’s payout ratio is 290.91%.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.